$RVTY
Revvity, Inc.
Life sciences and diagnostics company providing genomics, imaging, and testing solutions.
RVTY key facts as of November 14, 2026
- Latest AI research report
- RVTY Stock: Growth, Valuation and Risks (as of November 14, 2026)
- StockAlpha report sentiment
- Neutral (as of November 14, 2026)
- Analyst consensus
- Hold (0 Strong Buy, 6 Buy, 11 Hold, 0 Sell, 1 Strong Sell) (as of November 1, 2026)
- Analyst price target
- $151.43 mean (range $115.00 to $200.00) (as of November 20, 2026)
- Sector
- Healthcare
Analysis from Nov 14, 2026
RVTY Stock: Growth, Valuation and Risks
Revvity’s latest reported quarter beat the provided EPS estimate, while reported revenue growth remains modest and its trailing P/E is elevated. A Friday investor-day event and conflicting analyst target datasets add context, but the evidence points to a mixed outlook rather than a clear direction.
Previous Reports
RVTY FAQ
What is StockAlpha's latest view on RVTY?
StockAlpha's latest AI research report on Revvity, Inc. (RVTY), "RVTY Stock: Growth, Valuation and Risks", was published on November 14, 2026 and rates the overall sentiment as neutral. Revvity’s latest reported quarter beat the provided EPS estimate, while reported revenue growth remains modest and its trailing P/E is elevated. A Friday investor-day event and conflicting analyst target datasets add context, but the evidence points to a mixed outlook rather than a clear direction.
When was the RVTY research last updated?
The most recent RVTY report was published on November 14, 2026.
What do analysts expect for RVTY?
As of November 1, 2026, the analyst consensus on RVTY is Hold (0 Strong Buy, 6 Buy, 11 Hold, 0 Sell, 1 Strong Sell). As of November 20, 2026, the analyst price target is $151.43 mean (range $115.00 to $200.00).
Is this RVTY research investment advice?
No. StockAlpha.ai research is AI-generated analysis for informational purposes only and is not investment advice. Analyst figures are third-party data. Do your own research before making investment decisions.
Keep exploring
- draft Revvity into a free practice contest: How to put the stock you just researched into a contest lineup at no real-money risk
- the healthcare sector brief for context on Revvity's peers: Today's sector-level news and moves around the stock